neuro42

neuro42 is an early-stage, private medtech company pioneering a portable MRI and AI-powered robotic platform for neurosurgery. Its core innovation is a compact, low-field MRI system that can be used at the bedside or in the OR, providing real-time imaging to guide procedures like tumor resections, biopsies, and stroke interventions. Backed by over 40 patents and an FDA clearance, the company targets significant inefficiencies in traditional neuroimaging, aiming to make advanced care more accessible, faster, and less disruptive for patients. neuro42 is led by a team of experienced entrepreneurs and advised by prominent neurosurgeons and imaging scientists.

Portable low-field MRI system integrated with AI for image enhancement/analysis and robotics for surgical guidance.

neuro42 competes in the emerging portable/low-field MRI segment against companies like Hyperfine (NYSE: HYPR), as well as indirectly against high-field MRI manufacturers (Siemens, GE, Philips). Its differentiation is the tight integration with AI and robotics specifically tailored for neurosurgical guidance, rather than general diagnostic imaging.